L

L&C Bio Co Ltd
KOSDAQ:290650

Watchlist Manager
L&C Bio Co Ltd
KOSDAQ:290650
Watchlist
Price: 60 500 KRW 0.83% Market Closed
Market Cap: 1.5T KRW

Gross Margin
L&C Bio Co Ltd

51.9%
Current
51%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51.9%
=
Gross Profit
41.5B
/
Revenue
80B

Gross Margin Across Competitors

No Stocks Found

L&C Bio Co Ltd
Glance View

Market Cap
1.5T KRW
Industry
Biotechnology

L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-11-01. The firm mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The firm also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.

L&C Bio Co Ltd Intrinsic Value
HIDDEN
Show
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51.9%
=
Gross Profit
41.5B
/
Revenue
80B
What is the Gross Margin of L&C Bio Co Ltd?

Based on L&C Bio Co Ltd's most recent financial statements, the company has Gross Margin of 51.9%.

Back to Top